Trinity Biotech (TRIB) Intangibles (2016 - 2025)

Trinity Biotech has disclosed Intangibles across 10 years of filings, most recently posting $57.0 million for Q4 2025.

• Intangibles for Q4 2025 came in at $57.0 million, up 10.99% year-over-year; the trailing twelve-month figure through Dec 2025 was $57.0 million (up 10.99% YoY), and the FY2025 annual result was $57.0 million, up 10.99% from the prior year.
• Intangibles came in at $57.0 million for Q4 2025 at Trinity Biotech, up from $51.3 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $57.0 million in Q4 2025 to a low of -$8.5 million in Q4 2023.
• The 5-year median for Intangibles is $36.0 million (2021), against an average of $34.2 million.
• Across the five-year window, Intangibles slumped 124.24% in 2023 and surged 700.57% in 2024, its largest moves.
• Trinity Biotech's Intangibles stood at $36.0 million in 2021, then fell by 1.98% to $35.3 million in 2022, then tumbled by 124.24% to -$8.5 million in 2023, then soared by 700.57% to $51.3 million in 2024, then gained by 10.99% to $57.0 million in 2025.
• The last three Intangibles figures came in at $57.0 million (Q4 2025), $51.3 million (Q4 2024), and -$8.5 million (Q4 2023), per Business Quant data.